Hester Biosciences Ltd: Stock Analysis & Fundamentals

Updated this week

Hester Biosciences Ltd (Pharma - Animal) — fundamental analysis, earnings data, and key metrics. PE: 27.4. ROE: 9.2%. This stock is not currently in the Nifty 500 momentum outperformers list.

Key Numbers

Current Price

₹1,317

Dividend Yield

0.53%

Market Cap

1.1K Cr

Valuation

N/A

Other Top Pharma - Animal Stocks Beating Nifty 500

NGL Fine Chem Ltd

Strong • 9w streak

+72.0%

← Back to Pharma - Animal Dashboard

Frequently Asked Questions: Hester Biosciences Ltd

Based on publicly available financial data. This is educational research, not investment advice.

What were Hester Biosciences Ltd's latest quarterly results?

Hester Biosciences Ltd's latest quarterly results (Dec 2025) show

PAT Growth YoY: -18.3%
Revenue Growth YoY: +22.5%
Operating Margin: 23.0%

What is Hester Biosciences Ltd's current PE ratio?

Hester Biosciences Ltd's current PE ratio is 27.4x.

Current PE: 27.4x
Market Cap: 1.1K Cr
Dividend Yield: 0.53%

What is Hester Biosciences Ltd's price-to-book ratio?

Hester Biosciences Ltd's price-to-book ratio is 3.3x.

Price-to-Book (P/B): 3.3x
Book Value per Share: ₹397
Current Price: ₹1317

Is Hester Biosciences Ltd a fundamentally strong company?

Hester Biosciences Ltd's fundamental strength based on key financial ratios

Return on Capital (ROCE): 10.0%

Is Hester Biosciences Ltd debt free?

Hester Biosciences Ltd has a debt-to-equity ratio of N/A.

Total Debt: ₹214 Cr

What is Hester Biosciences Ltd's return on equity (ROE) and ROCE?

Hester Biosciences Ltd's return ratios over recent years

FY2023: ROCE 9.0%
FY2024: ROCE 9.0%
FY2025: ROCE 10.0%

Is Hester Biosciences Ltd's cash flow positive?

Hester Biosciences Ltd's operating cash flow is positive (FY2025).

Cash from Operations (CFO): ₹65 Cr
Free Cash Flow (FCF): ₹45 Cr
CFO/PAT Ratio: 224% (strong cash conversion)

What is Hester Biosciences Ltd's dividend yield?

Hester Biosciences Ltd's current dividend yield is 0.53%.

Dividend Yield: 0.53%
Current Price: ₹1317

Who holds Hester Biosciences Ltd shares — promoters, FII, DII?

Hester Biosciences Ltd's shareholding pattern (Dec 2025)

Promoters: 53.7%
FII (Foreign): 0.5%
DII (Domestic): 0.0%
Public: 45.8%

Is promoter holding increasing or decreasing in Hester Biosciences Ltd?

Hester Biosciences Ltd's promoter holding has remained stable recently.

Current Promoter Holding: 53.7% (Dec 2025)
Previous Quarter: 53.7% (Sep 2025)
Change: 0.00% (stable)

Is Hester Biosciences Ltd a new momentum entry or an established outperformer?

Hester Biosciences Ltd is an established outperformer with 1 weeks of consecutive Nifty 500 outperformance.

Is Hester Biosciences Ltd worth studying for long term investment?

Based on quantitative research signals, here is why Hester Biosciences Ltd may be worth studying

Cash flow is positive — CFO ₹65 Cr

What is the investment thesis for Hester Biosciences Ltd?

Hester Biosciences Ltd investment thesis summary:

What is the future outlook for Hester Biosciences Ltd?

Hester Biosciences Ltd's forward outlook based on current data signals

Insufficient data for a forward assessment — monitoring for more signals

The above FAQs are generated from publicly available earnings data and conference call transcripts. This is educational research only. Sector Alpha is not SEBI registered and does not provide investment advice.